Tatiana Zavorotinskaya

Author

University of Tennessee Health Science Center

Also Known As

T Zavorotinskaya, T. Zavorotinskaya, Tatiana Zavorotinskaya, Zavorotinskaya, Tatiana

Publications

810

Citations

H-Index

Concepts

All Affiliations

University of Tennessee Health Science Center Novartis (Switzerland)Novartis Institutes for BioMedical Research Novartis (United States)

About

Tatiana Zavorotinskaya is an author at University of Tennessee Health Science Center specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	255
2	Natural Sciences	3	3	102
3	Health Sciences	1	1	72
4	Allergy	1	1	46
5	Allergy Medicine	1	1	46

Tatiana Zavorotinskaya

Publications

739

Citations

H-Index

Page 1

	Year	Citations
Pim2 is required for maintaining multiple myeloma cell growth through modulating TSC2 phosphorylation Jing Lü, Tatiana Zavorotinskaya, Yumin Dai, Blood	2013	161
Pan-PIM Kinase Inhibition Provides a Novel Therapy for Treating Hematologic Cancers Pablo D. García, John L. Langowski, Yingyun Wang, Clinical Cancer Research	2014	110
Identification of <i>N</i>-(4-((1<i>R</i>,3<i>S</i>,5<i>S</i>)-3-Amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide (PIM447), a Potent and Selective Proviral Insertion Site of Moloney Murine Leukemia (PIM) 1, 2, and 3 Kinase Inhibitor in Clinical Trials for Hematological Malignancies Matthew T. Burger, Gisele Nishiguchi, Wooseok Han, Journal of Medicinal Chemistry Hematological MalignancyMoloney Murine LeukemiaMedicinal ChemistryKinase InhibitorMedicine	2015	72
Structure Guided Optimization, in Vitro Activity, and in Vivo Activity of Pan-PIM Kinase Inhibitors Matthew T. Burger, Wooseok Han, Jiong Lan, ACS Medicinal Chemistry Letters Drug TargetPan-pim Kinase InhibitorsChemical BiologyTumor BiologyMedicinal Chemistry	2013	52
Suppression of a Fusion Defect by Second Site Mutations in the Ecotropic Murine Leukemia Virus Surface Protein Tatiana Zavorotinskaya, Lorraine M. Albritton Journal of Virology	1999	48
Treatment of experimental asthma by long-term gene therapy directed against IL-4 and IL-13 Tatiana Zavorotinskaya, Adrian Tomkinson, John E. Murphy Molecular Therapy AsthmaInflammatory Lung DiseaseLung InflammationAllergy MedicineImmunology	2003	46
A Point Mutation in the Binding Subunit of a Retroviral Envelope Protein Arrests Virus Entry at Hemifusion Tatiana Zavorotinskaya, Zhaohui Qian, John Franks, Journal of Virology	2003	44
Orally Bioavailable Small-Molecule CD73 Inhibitor (OP-5244) Reverses Immunosuppression through Blockade of Adenosine Production Xiaohui Du, Jared T. Moore, Brian R. Blank, Journal of Medicinal Chemistry	2020	37
Analysis of the murine ecotropic leukemia virus receptor reveals a common biochemical determinant on diverse cell surface receptors that is essential to retrovirus entry Sandeep K. Malhotra, Alan G. Scott, Tatiana Zavorotinskaya, Journal of Virology Molecular VirologyBiochemistryAtrc1 ReceptorsMedicineImmunology	1996	35
Inhibition of prenylated KRAS in a lipid environment Johanna M. Jansen, Charles Wartchow, Wolfgang Jahnke, PLoS ONE Signal TransductionBiochemistryKras InhibitionRas MutationsNatural Sciences	2017	31

Page 1